المؤلفون: Lijian Wei, Yuting Tang, Zhuohua Wu, Pingyi Xu, Mingshu Mo

المصدر: Clinical Case Reports, Vol 10, Iss 10, Pp n/a-n/a (2022)

مصطلحات موضوعية: congenital afibrinogenemia, fibrinogen infusion, hemorrhagic complication, individualized treatment, thrombotic complication, Medicine, Medicine (General), R5-920

العلاقة: https://doi.org/10.1002/ccr3.6395Test; https://doaj.org/toc/2050-0904Test; https://doaj.org/article/667a8a612fff4df1be1ad50fbe53ff27Test

الإتاحة: https://doi.org/10.1002/ccr3.6395Test
https://doaj.org/article/667a8a612fff4df1be1ad50fbe53ff27Test

المؤلفون: Kirsten A. Kortekaas, Paul L. den Exter, Saskia L. M. A. Beeres, Meindert Palmen, J. Wouter Jukema, Menno V. Huisman, Laurens F. Tops

المصدر: Frontiers in Cardiovascular Medicine, Vol 9 (2022)

مصطلحات موضوعية: bleeding complication, left ventricular assist device (LVAD), pump thrombosis (PT), thrombolysis, thrombotic complication, Diseases of the circulatory (Cardiovascular) system, RC666-701

العلاقة: https://www.frontiersin.org/articles/10.3389/fcvm.2022.969766/fullTest; https://doaj.org/toc/2297-055XTest; https://doaj.org/article/074b2954ce28453baa89e4b0b15cf06dTest

الإتاحة: https://doi.org/10.3389/fcvm.2022.969766Test
https://doaj.org/article/074b2954ce28453baa89e4b0b15cf06dTest

المؤلفون: Skrypnikov, Vladimir, Rosenthal, Christoph, Weber-Carstens, Steffen, Menk, Mario, Russ, Martin

مصطلحات موضوعية: Hemorrhagic shock, Dynamic LVOT obstruction, SAM phenomenon, Pro-coagulatory therapy, Thrombotic complication, ddc:610

وصف الملف: application/pdf

العلاقة: https://refubium.fu-berlin.de/handle/fub188/38305Test; http://dx.doi.org/10.17169/refubium-38024Test

الإتاحة: https://doi.org/10.17169/refubium-38024Test
https://doi.org/10.1186/s13256-021-02840-3Test
https://refubium.fu-berlin.de/handle/fub188/38305Test

المؤلفون: Vladimir Skrypnikov, Christoph Rosenthal, Steffen Weber-Carstens, Mario Menk, Martin Russ

المصدر: Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-7 (2021)

مصطلحات موضوعية: Hemorrhagic shock, Dynamic LVOT obstruction, SAM phenomenon, Pro-coagulatory therapy, Thrombotic complication, Medicine

العلاقة: https://doi.org/10.1186/s13256-021-02840-3Test; https://doaj.org/toc/1752-1947Test; https://doaj.org/article/b330ce279d434755855439c89dc37fc8Test

الإتاحة: https://doi.org/10.1186/s13256-021-02840-3Test
https://doaj.org/article/b330ce279d434755855439c89dc37fc8Test

المؤلفون: Washington Alemán, MD, Leonardo Cano Cevallos, MD

المصدر: Radiology Case Reports, Vol 16, Iss 4, Pp 899-902 (2021)

مصطلحات موضوعية: Thrombotic disease, Covid-19, Venous thrombosis, Thrombotic complication, Medical physics. Medical radiology. Nuclear medicine, R895-920

العلاقة: http://www.sciencedirect.com/science/article/pii/S193004332100039XTest; https://doaj.org/toc/1930-0433Test; https://doaj.org/article/fbdc9e97fefd448b8cf9c71eb1ed8707Test

الإتاحة: https://doi.org/10.1016/j.radcr.2021.01.039Test
https://doaj.org/article/fbdc9e97fefd448b8cf9c71eb1ed8707Test

المؤلفون: Alessandro Allegra, Giovanni Pioggia, Alessandro Tonacci, Marco Casciaro, Caterina Musolino, Sebastiano Gangemi

المصدر: Antioxidants; Volume 9; Issue 11; Pages: 1037

مصطلحات موضوعية: myeloproliferative neoplasms, essential thrombocythemia, polycythemia vera, myelofibrosis, inflammation, oxidative stress, ROS, driver mutation, thrombotic complication

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/antiox9111037Test

الإتاحة: https://doi.org/10.3390/antiox9111037Test

المؤلفون: Saud Bin Abdul Sattar, Qasim Zafar Iqbal, Muhammad Adnan Haider, Zeeshan Zia, Muhammad Raphay Khan Niazi, Muhammad Hanif, Mukarram Jamat Ali, Muhammad Aslam Khan

المصدر: Frontiers in Medicine, Vol 7 (2020)

مصطلحات موضوعية: COVID-19, SARS- CoV-2, thrombotic complication, hypercoagulability, locked-in syndrome, Medicine (General), R5-920

العلاقة: https://www.frontiersin.org/article/10.3389/fmed.2020.574690/fullTest; https://doaj.org/toc/2296-858XTest; https://doaj.org/article/3fdfbd786f374a60b533f682df52179bTest

الإتاحة: https://doi.org/10.3389/fmed.2020.574690Test
https://doaj.org/article/3fdfbd786f374a60b533f682df52179bTest

المؤلفون: Kortekaas, K.A., Exter, P.L. den, Beeres, S.L.M.A., Palmen, M., Jukema, J.W., Huisman, M.V., Tops, L.F.

المصدر: Frontiers in Cardiovascular Medicine

مصطلحات موضوعية: bleeding complication, left ventricular assist device (LVAD), pump thrombosis (PT), thrombolysis, thrombotic complication

العلاقة: lumc-id: 176198670; https://hdl.handle.net/1887/3515788Test

الإتاحة: https://doi.org/10.3389/fcvm.2022.969766Test
https://hdl.handle.net/1887/3515788Test

المؤلفون: A. Vorob'ev V., U. Zimovina V., I. Kvikviniya Z., А. Воробьев В., У. Зимовина В., И. Квиквиния З.

المصدر: Obstetrics, Gynecology and Reproduction; Vol 8, No 2 (2014); 27-33 ; Акушерство, Гинекология и Репродукция; Vol 8, No 2 (2014); 27-33 ; 2500-3194 ; 2313-7347

مصطلحات موضوعية: hormone replacement therapy, thrombophilia, arterial thrombosis, prophylaxis of thrombotic complication, ЗАМЕСТИТЕЛЬНАЯ ГОРМОНАЛЬНАЯ ТЕРАПИЯ, ТРОМБОФИЛИЯ, АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, ПРОФИЛАКТИКА ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ

وصف الملف: application/pdf

العلاقة: https://www.gynecology.su/jour/article/view/74/75Test; Григорян О.Р., Андреева, Е.Н., Дедов И.И. Менопаузальный синдром у женщин с нарушениями углеводного обмена. Научно-практическое руководство (второе издание). М. 2011.; Макацария А.Д., Бицадзе О.В. Тромбофилические состояния в акушерской практике. М. 2001; 704 с.; Макацария А.Д., Мищенко А.Л., Бицадзе В.О. Синдром диссеминированного внутрисосудистого свертывания крови в акушерской практике. М. 2002; 523 с.; Макацария А.Д., Бицадзе О.В. Тромбофилии и противотромботическая терапия в акушерской практике. М. 2003; 904 с.; Овсянникова Т.В., Шешукова Н.А. Возможности заместительной гормональной терапии в зависимости от периода климактерия. Гинекология. 2007; 9 (2).; Beral V., Banks E., Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therap. Lancet. 2002; 360 (9337): 942-944.; Braunstein J.B., Kershner D.W., Bray P., Gerstenblith G. et al. Interaction of Hemostatic Genetics With Hormone Therapy: New Insights To Explain Arterial Thrombosis in Postmenopausal Women. Chest. 2002; 121 (3): 906-920.; Braunstein J.В., Kershner D.W, Gerstenblith G. et al. Interaction of Hemostatic Genetics With Hormone Therapy: New Insights To Explain Arterial Thrombosis in Postmenopausal Women. CHEST. 2002; 121: 906-20.; Brenner B.R., Kosch A., Manco-Johnson M., Laposata M. Diagnostic Studies for Thrombophilia in Women on Hormonal Therapy and During Pregnancy, and in Children. Arch. Pathol. Lab. Med. 2002; 126: 1296-303.; Cano A., Van Baal W M. The mechanisms of thrombotic risk induced by hormone replacement therapy. Maturitas. 2001; 40: 17-38.; Cushman M., Kuller L.H., Prentice R. et al. Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. J.A.M.A. 2004; 292 (13): 1573-80.; Cushman M. Effects of Hormone Replacement Therapy and Estrogen Receptor Modulators on Markers of Inflammation and Coagulation. Amer. J. Cardiol. 2002; 90: 7F-10F.; Girolami A., Simioni P., Tormene D. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems. Haematologica. 2000; 85 (3): 225-6.; Grodstein F., Manson J.E., Stampfer M.J. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. A prospective, observational study. Ann. Intern. Med. 2001; 135 (1): 1-8.; Goudev A., Georgiev D. В., Koycheva N. et al. Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. Maturitas. 2002; 43; 49-53.; Heckbert S.N.L., Lemaitre R.N., Reiner A. et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. J.A.M.A. 2004; 292 (13): 1581-7.; Herrington D.M., Klein K.P. Effects of Estrogen on Thrombosis and Inflammation. Rev. Cardiovasc. Med. 2002; 3 (1): 49-56.; Herkert O., Kuhl H., Sandow J., Busse R., Schini-Kerth V.B. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation. 2001 Dec 4; 104 (23): 2826-31.; Hodis H.N., Mack W.J., Lobo R.A. et al. Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2001; 135 (11): 939-53.; Hoibraaten E., Qvigstad E., Arnesen H. et al. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, doubleblind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb. Haemost. 2000; 84 (6): 961-967.; Khan M.A., Heagerty A.M., Kitchener H., McNamee R., Cherry' N.M., Hannaford P. Oestrogen and women's heart disease: ESPRIT-UK. QJM. 2000; 93 (10): 699-700.; Koh К.К. Effects of estrogen on the vascular wall: vasomotor function and Inflammation. Cardiovasc. Res. 2002; 55: 714-26.; Lowe G., Woodward M., Vessey M. et al. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy. Thromb. Haemost. 2000; 83 (4): 530-5.; Lu H., Higashikata T, Inazu A. et al. Association of Estrogen Receptor-a Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia. Arterioscler. Thromb. Vase. Biol. 2002; 22: 821-7.; Luyer P., Khosla S., Owen W.G., V. Miller. M. Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal Women. J. Clin. Endocrinol. Metab. 2001; 86: 3629-34.; Manson J.E., Hsia J., Johnson K.C. et al. Women’s Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 2003; 349 (6): 523-34.; Nelson H.D. Assessing Benefits and Harms of Hormone Replacement Therapy: Clinical Applications. JAMA. 2002; 288 (7): 882-884.; Psaty B.M., Smith N.L., Lemaitre R.N. et al. Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Myocardial Infarction in Postmenopausal Women. JAMA. 2001; 285 (7): 906-913.; Raghvendra K., Jackson E.K. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Amer. J. Physiol. Renal. Physiol. 2001; 280: F365-88.; Pare G., Krust A., Karas R. H., Dupont S., Aronovitz M., Chambon P., Mendelsohn M. E. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ. Res. 2002; 90 (10): 1087-92.; Peeyananjarassri K., Baber R. Effects of lowdose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric. 2005; 8 (1): 13-23.; Pradhan A.D., Manson J.A., Rossouw J.E. et al. Inflammatory biomarkers, hormone replacement therapy and incidence of coronary heart disease. J.A.M.A. 2002; 288: 980-7.; Rosendaal F.R., Vlieg A.V.H., Tanis B.C, Helmelhorst F.M. Estrogens, Progesterons and thorombosis. J. Thromb. Haemost. 2003; 1: 1371-80.; Rosendaal F.R., Vessey M., Rumley A. et al. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br. J. Haematol. 2002; 166 (4): 851-854.; Scarabin P.Y., Oger E., Plu-Bureau G. Estrogen and ThromboEmbolism Risk Study Group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 2003; 9382 (362): 428-432.; Schuit S.C.E., Oei H.H., Witteman J.C.M. et al. Estrogen Receptor Gene Polymorphisms and Risk of Myocardial Infarction. JAMA. 2004; 291 (24): 2969-2977.; Seelig M.S., Altura B.M., Altura В.Т. Benefits and Risks of Sex Hormone Replacement in Postmenopausal Women. J. Amer. Coll. Nutr. 2004; 23 (5): 482-96.; Stork S., van der Schouw Y.T., Grobbee D.E. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab. 2004; 15 (2): 66-72.; Tempfer C.B., Riener E.K., Hefler L.A., Huber J.C., Muendlein A. DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy. Fertil Steril. 2004; 82 (1): 132-137.; The Women’s Health Initiative Hormone Trials: Implications for Menopausal and Posmenopausal Women. 5th International Symposium on Women’s Health and menopause. Florence, 2004.; https://www.gynecology.su/jour/article/view/74Test

الإتاحة: https://www.gynecology.su/jour/article/view/74Test

المؤلفون: A. V. Vorob'ev, U. V. Zimovina, I. Z. Kvikviniya

المصدر: Акушерство, гинекология и репродукция, Vol 8, Iss 2, Pp 27-33 (2016)

مصطلحات موضوعية: hormone replacement therapy, thrombophilia, arterial thrombosis, prophylaxis of thrombotic complication, Gynecology and obstetrics, RG1-991

العلاقة: https://www.gynecology.su/jour/article/view/74Test; https://doaj.org/toc/2313-7347Test; https://doaj.org/toc/2500-3194Test; https://doaj.org/article/1c012141b95d437782d41cbc689b150bTest

الإتاحة: https://doaj.org/article/1c012141b95d437782d41cbc689b150bTest